Kymera Therapeutics Inc. (KYMR)
NASDAQ: KYMR
· Real-Time Price · USD
42.09
0.54 (1.30%)
At close: Aug 15, 2025, 12:49 PM
Kymera Therapeutics Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for KYMR stock have an median target of 57.5, with a low estimate of 44 and a high estimate of 70. The median target predicts an increase of 36.61% from the current stock price of 42.09.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 44 | 57.25 | 57.5 | 70 |
| Change | 4.54% | 36.02% | 36.61% | 66.31% |
Latest Analyst Insight Report
HC Wainwright & Co. maintains a Buy rating on Kyme... Unlock content with Pro Subscription
Updated Jun 26, 2025
| Rating | Dec 24 | Jan 25 | Feb 25 | Mar 25 | May 25 | Jun 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 0 | 0 | 2 |
| Buy | 3 | 1 | 0 | 1 | 4 | 4 |
| Hold | 1 | 0 | 0 | 0 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 1 | 1 | 1 | 6 | 6 |
Financial Forecast this Year
Revenue This Year
81.68M
from 47.07M
Increased by 73.5%
Revenue Next Year
60.61M
from 81.68M
Increased by -25.8%
EPS This Year
-3.32
from -2.98
Increased by -11.4%
EPS Next Year
-3.98
from -3.32
Increased by -19.9%